First, keep in mind that there is no "correct" way to do a valuation analysis for a stock. So, when anyone says a stock is "overvalued," that is just their opinion, not a fact. That said, it's widely ...

We believe Copart (CPRT) stock could represent a solid value investment. Currently, it is trading below the average valuation, while demonstrating acceptable revenue growth and strong profit margins ...

Oscar Health stock (NYSE: OSCR) has recently increased to over $16 after reports of a possible two-year extension of Obamacare subsidies, which may positively influence demand for health insurance via ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...

Before we dive in, let's get to know Palantir a bit better. The company has existed for more than 20 years, but it only launched an initial public offering back in 2020. Though it didn't immediately ...